Pulmonary Infection in the Immunocompromized Patient

  • J. Klastersky
Conference paper
Part of the Anaesthesiologie und Intensivmedizin / Anaesthesiology and Intensive Care Medicine book series (A+I, volume 178)


Infections are probably the most common curable causes of pneumopathies in the cancer patient. As shown in Table 1, pathogens can be bacteria, fungi, parasites or viruses [1]. Bacterial infections are important to identify because of the possible use of effective antibiotics; among them legionella has to become a more frequent problem [2].


Herpes Zoster Adult Respiratory Distress Syndrome Cytomegalovirus Infection Pneumococcal Pneumonia Open Lung Biopsy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Matthay RA, Greene WH (1980) Pulmonary infections in the immunocomprised patient. Med Clin North Am 64: 529 - 551PubMedGoogle Scholar
  2. 2.
    Haverkos HW, Dowling JN, Pasculle AW, et al (1983) Diagnosis of pneumonitis in immunocompro¬mised patients by open lung biopsy. Cancer 52: 1093 - 1097PubMedCrossRefGoogle Scholar
  3. 3.
    Fruchtman SM, Gombert ME, Lyons HA (1983) Adult respiratory distress syndrome as a cause of death in pneumococcal pneumonia. Report of ten cases. Chest 83: 598 - 601PubMedCrossRefGoogle Scholar
  4. 4.
    Fallat RJ, Milke CH, Rodvien R (1980) Adult respiratory distress syndrome and Gram-negative sepsis. Arch Intern Med 140: 612 - 613PubMedCrossRefGoogle Scholar
  5. 5.
    Meyers JD, Thomas ED (1981) Infection complicating bone marrow transplantation. In: Rubin PH, Young LS (eds) Clinical approach to infection in the compromised host. Plenum Medical Book New York, pp 507 - 551Google Scholar
  6. 6.
    Goodell B, Jacobs JB, Powell RD, et al (1970) Pneumocystis carinii: the spectrum of diffuse interstitial pneumonia in patients with neoplastic diseases. Ann Intern Med 72: 337 - 340PubMedGoogle Scholar
  7. 7.
    Meyers JD, Pifer LL, Sale GE, et al (1979) The value of Pneumocystis carinii antibody and antigen detection for diagnosis of Pneumocystis carinii pneumonia after marrow transplantation. Am Rev Respir Dis 120: 1283 - 1297PubMedGoogle Scholar
  8. 8.
    Ramsey PG, Fife KH, Hackman RC, et al (1983) Herpes simplex virus pneumonia. Clinical, virologic and pathologic features in 20 patients. Ann Intern Med 97: 813 - 820Google Scholar
  9. 9.
    Graham BS, Sneil JD (1983) Herpes simplex virus infection of the adult lower respiratory tract. Medicine 62: 384 - 393PubMedCrossRefGoogle Scholar
  10. 10.
    Betts RF (1982) Cytomegalovirus infection in transplant patients. Prog Med Viro 28: 44 - 64Google Scholar
  11. 11.
    Meyers JD, Flournoy N, Thomas ED (1982) Non bacterial pneumonia after allogenic marrow trans-plantation: a review often years’ experience. Rev Infect Dis 4: 1119 - 1132PubMedCrossRefGoogle Scholar
  12. 12.
    Winston DI, Ho WG, Young LS, et al (1980) Prophylactic granulocyte transfusions during human bone marrow transplantation. Am J Med 68: 893 - 897PubMedCrossRefGoogle Scholar
  13. 13.
    Hersman J, Meyers JD, Thomas ED, et al (1982) The effect of granulocyte transfusions on the inci-dence of cytomegalovirus infection after allogenic marrow transplantation. Ann Intern Med 96:149- 152PubMedGoogle Scholar
  14. 14.
    Meyers JD, Flournoy N, Thomas ED (1980) Cytomegalovirus infection and specific cell-mediated immunity after marrow transplant. J Infect Dis 142: 816 - 824PubMedCrossRefGoogle Scholar
  15. 15.
    Quinnan GV, Kirmani N, Rook AH, et al (1982) Cytoxic talls in cytomegalovirus infection. HLA-res- tricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from CMV infection in bone marrow transplant recipients. N Engl J Med 307: 6 - 13CrossRefGoogle Scholar
  16. 16.
    Goldstein LC, McDougall J, Hackman R, et al (1982) Monoclonal antibodies to cytomegalovirus: rapid identification of clinical isolates and preliminary use in diagnosis of cytomegalovirus pneumonia. Inf Immun 38: 273 - 281Google Scholar
  17. 17.
    Chou S, Merigan TC (1983) Rapid detection and quantitation of human cytomegalovirus in urine through DNA hybridation. N Engl J Med 308: 921 - 925PubMedCrossRefGoogle Scholar
  18. 18.
    Meyers JD, McGuffin RW, Bryson YT, Treatment of cytomegalovirus pneumonia after marrow transplant with combined vidarabine and human leukocyte interferonGoogle Scholar
  19. 19.
    Wade JC, Hintz M, McGuffin RW, et al (1982) Treatment of cytomegalovirus pneumonia with high- dose acyclovir. Am J Med 73: 249 - 256PubMedCrossRefGoogle Scholar
  20. 20.
    Winston DJ, Pollard RB, Ho WG, et al (1982) Cytomegalovirus immune plasma in bone marrow trans-plant recipients. Ann Intern Med 97: 11 - 18PubMedGoogle Scholar
  21. 21.
    Meyers JD, Leszczynski J, Zaia JA, et al (1982) Prevention of cytomegalovirus infection by cytome-galovirus immune globulin after marrow transplantation. Ann Intern Med 98: 442 - 446Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1985

Authors and Affiliations

  • J. Klastersky

There are no affiliations available

Personalised recommendations